Perrigo (PRGO) Change in Inventory (2013 - 2026)
Perrigo's (PRGO) quarterly Change in Inventory came in at -$23.6 million in Q1 2026, down 137.76% year-on-year from $62.5 million in Q1 2025, and up 71.43% on a QoQ basis from -$82.6 million in Q4 2025.
Perrigo (PRGO) Change in Inventory (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Change in Inventory data on file, last reported at -$23.6 million in Q1 2026.
- On a quarterly basis, Change in Inventory fell 137.76% year-over-year to -$23.6 million in Q1 2026; TTM through Mar 2026 was -$25.0 million, a 142.09% decrease from a year earlier, with the FY2025 full-year figure at $61.1 million, up 545.99% from the prior year.
- Change in Inventory for Q1 2026 stood at -$23.6 million, up from -$82.6 million in the prior quarter.
- Over the last five years, Change in Inventory for PRGO reached as high as $62.5 million in Q1 2025 and fell as low as -$82.6 million in Q4 2025.
- Historically, Change in Inventory has averaged $1.9 million across 5 years, with a median of $6.4 million in 2022.
- Across the five-year window, Change in Inventory sank 1085.71% in 2023 and jumped 689.62% in 2025, its largest moves.
- Year by year, Change in Inventory stood at -$2.1 million in 2022, then sank by 1085.71% to -$24.9 million in 2023, then decreased by 14.06% to -$28.4 million in 2024, then plunged by 190.85% to -$82.6 million in 2025, then surged by 71.43% to -$23.6 million in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were -$23.6 million in Q1 2026, -$82.6 million in Q4 2025, and $46.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -23.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -23.60 Mn |
| Mar 28, 2026 | -23.60 Mn |
| Dec 31, 2025 | -82.60 Mn |
| Dec 31, 2025 | -82.60 Mn |
| Sep 27, 2025 | 46.30 Mn |
| Sep 27, 2025 | 46.30 Mn |
| Jun 28, 2025 | 34.90 Mn |
| Jun 28, 2025 | 34.90 Mn |
| Mar 29, 2025 | 62.50 Mn |
| Mar 29, 2025 | 62.50 Mn |
| Dec 31, 2024 | -28.40 Mn |
| Dec 31, 2024 | -28.40 Mn |
| Sep 28, 2024 | 11.80 Mn |
| Sep 28, 2024 | 11.80 Mn |
| Jun 29, 2024 | 13.50 Mn |
| Jun 29, 2024 | 13.50 Mn |
| Mar 30, 2024 | -10.60 Mn |
| Mar 30, 2024 | -10.60 Mn |
| Dec 31, 2023 | -24.90 Mn |
| Dec 31, 2023 | -24.90 Mn |